NEOVASCULOSTOP – An early-stage research project with the approach to elicit a paradigm shift in how we design future drug delivery strategies to the retina. The novel strategy of drug targeting will not only enrich the modified molecules in retinal tissue but will also reduce the therapeutic oral dose compared to existing anti-angiogenic therapy thereby increasing the safety of the treatment.